期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

RAS-RAF-MEKl/2/-ERKl/2 MAPK信号转导通路及其与皮肤肿瘤的关系 被引量：5

The Relationship Between RAS-RAF-MEKl/2/-ERKl/2 MAPK Signal Transduction Pathway and Skin Cancer
下载PDF
导出
摘要 RAS-RAF-MEKl/2/-ERKl/2 MAPK信号转导通路是Ras基因下游通路中十分经典的也是研究得比较清楚的一条,且这条信号通路与多种肿瘤的发生和发展关系密切。针对目前这条通路与病理性瘢痕及瘢痕癌的关系的研究报道较少,本文就这条信号转导通路与皮肤肿瘤的关系作一综述。 RAS-RAF-MEK1/2/-ERKL/2 MAPK signal transduction pathway is the downstream of Ras gene pathway, which is one of tile most classic and relatively clear studies and this signaling pathway is closely related with the appearance and progression of the variety tumors. At present in the path and pathological scar and scar the relationship of cancer reported lower, the signal transduction pathways and article skin tumor relationship are reviewed in this paper.
作者 王海青 郭瑞珍
机构地区 遵义医学院珠海校区病理学教研室
出处 《中国皮肤性病学杂志》 CAS 北大核心 2013年第2期201-203,207,共4页 The Chinese Journal of Dermatovenereology
关键词 MAPK 信号通路 皮肤肿瘤 MAPK Signal transduction Skin cancer
分类号 R739.5 [医药卫生—肿瘤]
  • 相关文献

参考文献28

  • 1Raman M,Chen W,Cobb MH. Differential regulation and properties of MAPKs[J].Oncogene,2007,(22):3100-3112.doi:10.1038/sj.onc.1210392.
  • 2McCubrey JA,Steelman LS,Chappell WH. Roles of the Raf/MEK/ERKpathway in cell growth,malignant transformation and drug resistance[J].Biochimica Et Biophysica Acta,2007,(08):1263-1284.
  • 3Sato S,Fujita N,Tsuruo T. Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathway[J].Journal of Biological Chemistry,2004,(32):33759-33767.
  • 4H agemann C,Blank JL. The ups and downs of MEK kinase in-teractions[J].Cellular Signalling,2001,(12):863-875.
  • 5Vakiani E,Solit DB. KRAS and BRAF:drug targets and predictive biomarkers[J].Journal of Pathology,2011,(02):219-229.
  • 6Bos JL,Rehmann H,Wittinghofer A. GEFs and GAPs:critical element in the controlof small G proteins[J].Cell,2007,(05):865-877.doi:10.1016/j.cell.2007.05.018.
  • 7Wong KK. Recent developments in anticancer agents targeting the Ras/Raf/ MEK/ERK pathway[J].Recent Pat Anticancer Drug Discov,2009,(01):28-35.
  • 8Tamamori-Adachi M,Ito H,Sumrejkanchanakij P. Critical role of cyclin D1nuclear import in cardiomyocyte proliferation[J].Circulation Research,2003,(01):12-19.
  • 9Pons M,Quintanilla M. Molecular biology of malignant melanoma and other cutaneous tumors[J].Clin Transl oncol,2006,(07):466-474.
  • 10Uribe P,Gonzalez S. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin:molecular bases for EGFR-targeted therapy[J].Patnol Res Prast,2011,(06):337-342.

二级参考文献10

  • 1Schubbert S, Shannon K, Bollag G. Hyperactive RAS in develop- mental disorders and cancer [ J]. Nat Rev Cancer, 2007,7 ( 4 ) :295 - 308.
  • 2Akslen L A, Angelini S, Straume O, et al. BRAF and NRAS mu- tations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival [ J ]. J Invest Dermatol, 2005,125 (2) :312 -7.
  • 3Tanikawa E, Mori O, Hachisuka H, Sasai Y. Expression of ras proto - oncogene related protein p21 in normal human skin and cutaneous tumours[J]. Aeta Histoehem, 1992,93(1) :282 -9.
  • 4Platz A, Jungnelius U, GrafstrSm E, et al. Glutathione transferase PI-1 expression in human melanoma metastases: correlation to N- RAS mutations and expression [ J ]. Acta Oncol, 1995,34 ( 6 ) :759 - 65.
  • 5Stites E C, Ravichandran K S. A systems perspective of ras signa- ling in cancer[J]. Clin Cancer Res, 2009,15(5) :1510 -3.
  • 6Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival[J]. J Cell Mol Med, 2005,9( 1 ) :59 - 71.
  • 7Neill G W, Ghali L R, Green J L, et al. Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Glil in basal cell carcinoma[ J]. Cancer Res, 2003,63 ( 15 ) :4692 - 7.
  • 8Goodwin J S, Drake K R, Rogers C, et al. Depalmitoylated RAS traffics to and from the Golgi complex via a nonvesicular pathway [J]. J Cell niol, 2005,170(2):261 -72.
  • 9Kikuchi A, Amagai M, Hayakawa K, et al. Association of EGF receptor expression with proliferating cells and of ras p21 expression with differentiating cells in various skin tumours [ J ]. Br J Dermatol, 1990,123 ( 1 ) :49 - 58.
  • 10甄时建,杨举伦.以ras信号通路为靶标的抗肿瘤治疗研究进展[J].临床与实验病理学杂志,2008,24(5):607-611. 被引量：7

共引文献2

同被引文献69

  • 1王川颖.超脉冲二氧化碳点阵激光在中重度凹陷性痤疮瘢痕的疗效观察[J].中国医疗美容,2014,4(2):60-61. 被引量：17
  • 2李文伟.中西医综合治疗医源性周围神经损伤14例报告[J].中医正骨,2006,18(1):33-34. 被引量：16
  • 3连昕,林能兴,涂亚庭.磷酸化Stat3和磷酸化Akt及磷酸化ERK1/2在表皮良恶性肿瘤中的表达[J].中华皮肤科杂志,2007,40(7):434-436. 被引量：3
  • 4崔巍,王硕仁,朱陵群,等.平均光密度值分析法和阳性染色面积分析法在免疫组化图像分析中的对比研究[A].2008中华中医药学会内科分会中医内科学科建设研讨会论文汇编,2008:148-151.
  • 5McCubreyJA, Steelman LS, Chappell WH, et al. Roles of the Raf/ MEKIERK pathway in cell growth, malignant transformation and drug resistance[J] . Biochim Biophys Acta ,2007 ,1773 (8) : 1263 - 1284.
  • 6Wong KK. Recent developments in anti-cancer agents targeting the Ras/ Raf/MEKIERK pathway[J]. Recent Pat Anticancer Drug Discov, 2009 ,4( 1) :28 -35.
  • 7Lee SH, Shin MS, Kim HS, et al. Somatic mutations of Fas (Apo-ll CD95 ) gene in cutaneous squamous cell carcinoma arising from a bum scar] J J. TheJournal of Investigative Dermatology ,2000 ,114 ( I ) : 122 -126.
  • 8ObaJ ,Nakahara T ,Abe T ,et al. Expression of c-Kit,p-ERK and cyclin 01 in malignant melanoma: an immunohistochemical study and analysis of prognostic value[J].J Dermatol Sci ,2011 ,62( 2) : 116 -123.
  • 9Ebisuya M, Kondoh K, Nishida E. The duration, magnitude and compart?mentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity[J] .J Cell Sci, 2005 ,118 (14 ) : 2997 - 3002.
  • 10Huang 0, Ding Y ,Luo WM, et al. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vi?vo[J]. Cancer Res,2008,68(1) :81-88.

引证文献5

二级引证文献48

中国皮肤性病学杂志
2013年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部